$20,000 invested in CBA shares just 1 week ago is now worth…

Here's how painful it has been for CBA shareholders in the past week.

| More on:
A man with his back to the camera holds his hands to his head as he looks to a jagged red line trending sharply downward representing the ASX tech share sell-off today

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • The Commonwealth Bank of Australia's (CBA) share price dropped 10.6% in early November 2025, significantly impacting investors' returns.
  • CBA's recent quarterly results showed limited profit growth with a 6.1% increase in costs and a decline in the CET1 ratio, raising concerns about future performance.
  • UBS predicts a potential further 20% decline in CBA's share price over the next year, influenced by its FY26 profit projections and current high valuation.

The Commonwealth Bank of Australia (ASX: CBA) share price has had a painful November 2025 to date, as the chart below shows.

Over the long-term, owning CBA shares has been a positive investment. However, the short-term has been a painful ride.

With the bank still trading at a relatively high price/earnings (P/E) ratio and high price to book ratio, it needed to demonstrate strong profit generation in its FY26 first quarter numbers. This didn't eventuate, which i'll get into later.

First, let's take a look at how far a $20,000 investment has declined.

Pain for owners of CBA shares

The pre-open price on Monday 10 November 2025 was $175.91, representing a weekly decline of 10.6%.

That means a $20,000 investment has now become worth approximately $17,880. In other words, a fall of more than $2,100 if someone had $20,000 invested in CBA shares a week ago.

Of course, it's normal for there to be occasional volatility on the ASX share market. However, this is a very large decline for a business with a market capitalisation of well over $250 billion, according to the ASX.

What has caused the decline for the ASX bank share?

The bank reported a cash net profit of around 2.6% billion. This was only 1% higher than the quarterly average of the second half of FY25.

When UBS saw the result, the broker wrote:

Quarterly results have historically been unpredictable, making it challenging to form a definitive view on this release due to limited information. However, the headline figures indicate that CBA is delivering results broadly in line with expectations for 1H 26, as reflected in consensus estimates and UBSe forecasts. The 6.1% QoQ increase in costs is somewhat surprising, even excluding notable items, as is the decline in the CET1 ratio to 11.75%, compared to the 1H 26 consensus estimate of 12.3%.

Further credit RWA optimization at CBA appears limited relative to peers, given the substantial progress already made by the bank. We believe these results could impact the stock's performance. Over the past month, CBA's share price has risen 3.91%, outperforming NAB and WBC but lagging ANZ, which gained 8.95%. Given the current valuation, it would appear perfection is implicitly expected.

Broker UBS has a price target of $125 on the CBA share price, implying a possible fall of another 20% over the next year.

The broker is predicting that the bank could generate $10.75 billion of net profit in FY26, which could be a key influence on the CBA share price within the next 12 months.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man in a suit smiles at the yellow piggy bank he holds in his hand.
Share Market News

Forget Westpac shares, these ASX ETFs could be better buys

Here's why these funds could be quality picks for investors looking for alternatives to the banks.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another tough day for investors.

Read more »

Rising real estate share price.
REITs

Macquarie names its top 4 ASX REITs to buy today

Macquarie expects these four dividend paying ASX REITs will all surge higher in 2026.

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

Man with virtual white circles on his eye and AI written on top, symbolising artificial intelligence.
Broker Notes

Why this ASX AI stock could return 40% in 2026

Let's see which stock Bell Potter is tipping to rise strongly.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Share Market News

Analysts name 2 top ASX 200 shares to buy today

Leading investment experts name two quality ASX 200 shares to buy now.

Read more »

Woman leaping in the air and standing out from her friends who are watching.
Broker Notes

This ASX 200 gold stock has surged 77% in 2025. Here's why Macquarie expects it to leap another 23%

Macquarie forecasts 23% upside for this surging ASX gold stock, and that doesn’t include the dividends!

Read more »